ISTA Pharmaceuticals Inc. won FDA approval of Vitrase for use as a spreading agent to facilitate the dispersion and absorption of other drugs. Meanwhile, the firm is awaiting approval on an earlier new drug application for Vitrase as a single injection to the eye for vitreous hemorrhage. (BioWorld Today) Read More
